Vestibular Migraine: What to Do When Single-Agent Triptan Therapy Fails to Achieve Pain Relief at 2 Hours
When a patient with vestibular migraine is treated with a triptan as a single agent and does not achieve pain-free status within 2 hours, a structured next-line approach is indicated to gain adequate attack control and prevent recurrence.
Previous Treatment — Inadequate Response
Single-agent triptan therapy (monotherapy) was used for the attack. The defined treatment goal — pain-free at 2 hours — was not reached, which triggers escalation to the next protocol step.
Next-Line Approach
The next step involves combination therapy — a triptan paired with a long-acting NSAID. This approach targets both immediate pain relief and the prevention of attack recurrence. The specific agents and structured regimen are detailed in the full protocol.
Treatment goals: Pain-free after 2 hours & prevention of migraine attack recurrence.
References
DOI: 10.1177/2514183X1882337
- The initial combination of a triptan with a long-acting NSAID (such as naproxen) is more effective than the individual components and can in part prevent the recurrence of migraine attacks.
- In unsatisfactory effectiveness of a triptan, the triptan may be combined with a rapid-acting NSAID.